Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,969.00
Bid: 1,969.00
Ask: 1,971.00
Change: -31.00 (-1.55%)
Spread: 2.00 (0.102%)
Open: 2,008.00
High: 2,012.00
Low: 1,958.00
Prev. Close: 2,000.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday tips round-up: Hikma, African Barrick, Lenovo

Fri, 17th Aug 2012 06:58

What a difference a year makes, Tempus in The Times proclaims. When the Arab Spring was in full flow, investors worried that Hikma Pharmaceuticals was too exposed to the unstable region. The company, based in Jordan, almost halved last year's sales growth forecast as governments fell. Now it looks well placed to benefit from the region's recovery ? and investors are grateful that it has largely escaped the eurozone crisis, which has seen governments slash healthcare spending. The company is gradually shifting production to the developing world, where costs are cheaper. Analysts say that Hikma has better growth prospects than its European rivals, a view confirmed by yesterday's results. Shares rose five per cent yesterday, but are still off the high reached before the Arab Spring unfolded. Now an Arab Spring premium should apply. Buy, says Tempus.Hold African Barrick Gold (ABG) until the bid situation becomes clear is the advice of Questor in the Daily Telegraph. Two state-owned companies have approached African Barrick Gold's (ABG) parent company Barrick Gold with a view to making an offer for part, or whole, of ABG. Barrick Gold is continuing talks with China National Gold, after it apparently rejected a low-ball bid from Zijin Mining Group. Questor thinks Barrick Gold is more likely to sell a portion of its stake rather than sell out completely. This latest move by China may or may not mark the start of a wave of mergers in gold miners. However, the sector certainly looks ripe for consolidation for companies with the financial muscle to buy quality assets. Questor last said ABG shares were a speculative buy on July 24th when they stood at 317p. They are now 34% above that level and because the bid situation is unclear, the rating is now cut to hold.Chinese companies know all about "zouchuqu" - going out and staking a claim in global markets whatever the cost, observes Lex, as the Financial Times's venerable column takes a look at the world's second largest PC maker, Lenovo. On Thursday, the PC maker said that in the past three months it increased revenues 35% from a year earlier, and widened its paper-thin margins enough to increase operating profit by nearly 50%. Good work, but there is more to be done. While Lenovo's share in the PC market is now just short of global leader Hewlett-Packard's, its operating margins are a quarter of HP's. Progress may take time, though. This month it announced a partnership with EMC, the US storage server group that once worked with Dell. Margins are fatter in the server market, but Lenovo will be up against tough competitors in HP, IBM and Dell, who control three-quarters of it. However, any Chinese company that has proved it can combine global ambition and improving profitability deserves the benefit of the doubt.Please note: Digital Look provides a round-up of news, tips and information that is impacting share prices and the market. Digital Look cannot take any responsibility for information provided by third parties. This is for your general information only as not intended to be relied upon by users in making an investment decision or any other decision. Please obtain a copy of the relevant publication and carry out your own research before considering acting on any of this information.JH
More News
29 Apr 2022 17:01

LONDON MARKET CLOSE: Stocks end volatile April on high note

(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while markets in the US sank as high-profile tech names disappointed.

Read more
29 Apr 2022 09:09

Hikma Pharmaceuticals notes "slow" start for Generics business in 2022

(Alliance News) - Hikma Pharmaceuticals PLC said on Friday that both its Injectables and Branded businesses have performed well at the start of the year but noted its Generics business has experienced some headwinds.

Read more
29 Apr 2022 08:32

Hikma shares fall as generics unit faces headwinds

(Sharecast News) - Hikma Pharmaceuticals shares fell as the company reported headwinds at its generics business.

Read more
29 Apr 2022 08:25

LONDON BRIEFING: Pearson has positive first quarter, buys language app

(Alliance News) - Educational materials publisher Pearson on Friday provided a positive update on first quarter trading, while also announcing a new acquisition.

Read more
21 Apr 2022 16:06

UK dividends calendar - next 7 days

Friday 22 April 
JPMorgan Global Emerging Markets Income Trust PLCdividend payment date
Henderson Eurotrust PLCdividend payment date
Monday 25 April 
abrdn Smaller Cos Income Trust PLCdividend payment date
Tuesday 26 April 
Anglo American PLCdividend payment date
Anglo American PLCspecial dividend payment date
Invesco Asia Trust PLCdividend payment date
Wednesday 27 April 
Close Brothers Group PLCdividend payment date
Thursday 28 April 
4imprint Group PLCex-dividend date
AEW UK REIT PLCex-dividend date
AVI Japan Opportunity Trust PLCex-dividend date
Bakkavor Group PLCex-dividend date
Carr's Group PLCex-dividend date
Coats Group PLCex-dividend date
CQS Natural Resources Growth & Income PLCex-dividend date
CQS New City High Yield Fund Ltdex-dividend date
Derwent London PLCex-dividend date
Drax Group PLCex-dividend date
Ecofin Global Utilities & Infrastructure Trust PLCex-dividend date
Fresnillo PLCex-dividend date
Henderson Far East Income Trust PLCex-dividend date
Hikma Pharmaceuticals PLCdividend payment date
HSBC Holdings PLCdividend payment date
Kenmare Resourcesex-dividend date
LSL Property Services PLCex-dividend date
M&G PLCdividend payment date
M P Evans Group PLCex-dividend date
Mobius Investment Trust PLCex-dividend date
Morgan Advanced Materials PLCex-dividend date
Morgan Sindall Group PLCex-dividend date
Mortgage Advice Bureau (Holdings) PLCex-dividend date
Northamber plcdividend payment date
Porvair PLCex-dividend date
Reckitt Benckiser Group PLCex-dividend date
Rightmove PLCex-dividend date
Sabre Insurance Group PLCex-dividend date
Sabre Insurance Group PLCspecial ex-dividend date
Schroder Oriental Income Fund Ltdex-dividend date
Secure Income REIT PLCex-dividend date
Smart Metering Systems PLCdividend payment date
St James's Place PLCex-dividend date
Synthomer PLCex-dividend date
Tate & Lyle PLCspecial ex-dividend date
TT Electronics PLCex-dividend date
Tyman PLCex-dividend date
XP Power Ltddividend payment date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
21 Apr 2022 14:37

IN BRIEF: Hikma Pharmaceuticals completes Custopharm deal

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Completes acquisition of Custopharm Inc from Water Street Healthcare Partners, following approval from the US Federal Trade Commission. Back in September, Hikma agreed to buy the California-based generic injectable products company for a total of up to USD425 million. Deal will add up to 13 approved products and additional pipeline products.

Read more
20 Apr 2022 09:16

IN BRIEF: Hikma gets preliminary US approval for Custopharm acquisition

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Receives preliminary approval from the US Federal Trade Commission for its planned acquisition of Custopharm Inc. Back in September, Hikma agreed to buy the California, US-based generic injectable products company for a total of up to USD425 million.

Read more
20 Apr 2022 07:39

Hikma gets preliminary approval from US FTC for Custopharm deal

(Sharecast News) - Hikma Pharmaceuticals has received preliminary approval from the US Federal Trade Commission for the acquisition of sterile injectables company Custopharm Inc from Water Street Healthcare for up to $425m.

Read more
12 Apr 2022 10:11

LONDON BROKER RATINGS: JPMorgan lowers Rolls-Royce; UBS likes Ryanair

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
10 Mar 2022 16:10

UK dividends calendar - next 7 days

Friday 11 March  
Avon Protection PLCdividend payment date
Civitas Social Housing PLCdividend payment date
Impact Healthcare REIT PLCdividend payment date
Virgin Money UK PLCdividend payment date
Monday 14 March  
Tritax EuroBox PLCdividend payment date
Tuesday 15 March 
Hipgnosis Songs Fund Ltddividend payment date
Invesco Perpetual UK Smaller Cos Investment Trust PLCdividend payment date
Merchants Trust PLCdividend payment date
Wednesday 16 March  
no events scheduled 
Thursday 17 March  
Anglo American PLCex-dividend date
Anglo American PLCspecial ex-dividend date
Bellevue Healthcare Trust PLCex-dividend date
Blackrock Income & Growth Investment Trust PLCdividend payment date
BlacKRock World Mining Trust PLCex-dividend date
Brooks Macdonald Group PLCex-dividend date
Crest Nicholson Holdings PLCex-dividend date
Dunelm Group PLCex-dividend date
FW Thorpe PLCex-dividend date
FW Thorpe PLCspecial ex-dividend date
Gore Street Energy Storage Fund PLCex-dividend date
HgCapital Trust PLCex-dividend date
Hikma Pharmaceuticals PLCex-dividend date
Ideagen PLCdividend payment date
JPMorgan Mid Cap Investment Trust PLCex-dividend date
Knights Group Holdings PLCdividend payment date
M&G PLCex-dividend date
Murray Income Trust PLCdividend payment date
NatWest Group PLCex-dividend date
RM PLCex-dividend date
Segro PLCex-dividend date
Spirent Communications PLCex-dividend date
Standard Life Private Equity Trust PLCex-dividend date
Treatt PLCdividend payment date
Trifast PLCex-dividend date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
3 Mar 2022 10:02

LONDON BROKER RATINGS: Downgrades for Hikma Pharma and Royal Mail

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
3 Mar 2022 08:28

LONDON BRIEFING: LSEG says Refinitiv savings bigger, ahead of schedule

(Alliance News) - London Stock Exchange Group on Thursday said 2021 was a successful year following the acquisition of Refinitiv, leaving the stock exchange operator well positioned as a financial market infrastructure and data business.

Read more
2 Mar 2022 09:52

LONDON BROKER RATINGS: Downgrades for AB Foods, BT and Royal Mail

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 Feb 2022 09:40

IN BRIEF: Hikma Pharmaceuticals launches first phase of share buyback

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Instructs Citigroup Global Markets Ltd, part of Citigroup Inc, to conduct the USD150 million first tranche of the USD300 million share buyback that it announced on Thursday. The initial phase will begin on Friday and end by June 25. Hikma had announced the buyback programme with its annual results, saying it reflected its strong cash generation, balance sheet strength, and confidence in future growth prospects. Hikma also had declared a final dividend of 36 cents, a 5.9% boost from a shareholder payout of 34 cents the year before. Its full-year dividend amounted to 54 US cents, up 8.0% from 50 cents.

Read more
25 Feb 2022 08:22

LONDON BRIEFING: IAG expects to fly 85% of pre-virus capacity in 2022

(Alliance News) - International Consolidated Airlines Group on Friday posted a narrowed loss for 2021, saying that after the setback caused by Omicron at the end of the year, bookings have rebounded strongly and it expects to fly 85% of its 2019 capacity in 2022.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.